Illumina, Inc. (ILMN) Acquires EPICENTRE Biotechnologies, Leading Provider of Nucleic Acid Sample Preparation Reagents and Specialty Enzymes
1/12/2011 10:07:10 AM
More...
|
Partial Vaccine Dose May Work As Well As Full Shot, EPICENTRE Biotechnologies Study
12/2/2008 7:15:50 AM
More...
|
EPICENTRE Biotechnologies Announces the Best Option for Labeling Target RNA for the Illumina(R) Gene Expression System
12/4/2007 11:25:51 AM
More...
|